» Articles » PMID: 1571199

SIV/HIV Recombinants and Their Use in Studying Biological Properties

Overview
Publisher Mary Ann Liebert
Date 1992 Mar 1
PMID 1571199
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

A series of chimeric clones between human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency viruses (SIV) were constructed. Viability of the recombinant viruses was dependent on the position of recombination. Infectious chimeric viruses between HIV-1 and SIVAGM (isolated from an African green monkey) and those between HIV-1 and SIVMAC (isolated from a rhesus monkey) were examined for host cell tropism. Viral determinants that restrict the replication of SIVAGM in human MT-4 cells and that of HIV-1 in macaque monkey peripheral blood mononuclear cells (PBMC) mapped to the 5' half of the virus genome. One HIV-1/SIVMAC chimera which contained the HIV-1 env gene was shown to replicate in macaque PBMC in vitro and to infect macaque monkeys in vivo. This HIV-1/SIVMAC chimera will be useful for a variety of AIDS pathogenesis and vaccine studies.

Citing Articles

CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques.

Doi N, Miura T, Mori H, Sakawaki H, Koma T, Adachi A Front Microbiol. 2018; 9:2510.

PMID: 30405570 PMC: 6200915. DOI: 10.3389/fmicb.2018.02510.


Understanding restriction factors and intrinsic immunity: insights and lessons from the primate lentiviruses.

Kirmaier A, Krupp A, Johnson W Future Virol. 2015; 9(5):483-497.

PMID: 26543491 PMC: 4630824. DOI: 10.2217/FVL.14.25.


Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors.

Saito A, Akari H Front Microbiol. 2013; 4:187.

PMID: 23847610 PMC: 3705164. DOI: 10.3389/fmicb.2013.00187.


Species tropism of HIV-1 modulated by viral accessory proteins.

Nomaguchi M, Doi N, Matsumoto Y, Sakai Y, Fujiwara S, Adachi A Front Microbiol. 2012; 3:267.

PMID: 22855686 PMC: 3405772. DOI: 10.3389/fmicb.2012.00267.


Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials.

Shedlock D, Silvestri G, Weiner D Nat Rev Immunol. 2009; 9(10):717-28.

PMID: 19859066 PMC: 4317297. DOI: 10.1038/nri2636.